Stock Events

Stock Events

Seelos Therapeutics 

$0.000100
99
+$0.00+0% Wednesday 20:00
+$0.00+0%Friday 21:42After hours

Statistics

Day High
0.0001
Day Low
0.0001
52W High
0.01
52W Low
0.0001
Volume
100
Avg. Volume
0
Mkt Cap
595.7
P/E Ratio
0
Dividend Yield
-
Dividend
-

Earnings

7MarExpected
Q4 0
Q2 2024
Q3 2024
Q4 2024
-162.09
-135.96
-109.83
-83.7
Expected EPS
-83.6992
Actual EPS
N/A

Financials

-1,719.56%Profit Margin
Unprofitable
2018
2019
2020
2021
2022
2023
2.2MRevenue
-37.88MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow SEELQ. It's not an investment recommendation.
Microsoft
2
MSFT
Amazon
2
AMZN
Alphabet
2
GOOGL
ASML NV
2
ASML

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Axsome Therapeutics
AXSM
Mkt Cap10.42B
Axsome Therapeutics develops novel therapies for central nervous system disorders, similar to Seelos' focus, making them direct competitors.
Alkermes
ALKS
Mkt Cap7.95B
Alkermes plc works on developing innovative medicines for neurological and psychiatric disorders, overlapping with Seelos' therapeutic areas.
BridgeBio Pharma
BBIO
Mkt Cap14.97B
BridgeBio Pharma targets genetic diseases and genetically defined cancers, including neurological disorders, competing in the same innovative therapeutic area as Seelos.
Biogen
BIIB
Mkt Cap32.28B
Biogen focuses on neurology, making it a competitor by developing treatments for diseases in similar domains as Seelos.
AMGEN
AMGN
Mkt Cap233.78B
Amgen's broad focus on innovative therapeutics includes neurological conditions, positioning it as a competitor to Seelos.
Novartis
NVS
Mkt Cap292.35B
Novartis offers a wide range of healthcare solutions, including treatments for neurological conditions, making it a competitor in the same market as Seelos.
Pfizer
PFE
Mkt Cap159.36B
Pfizer has a diverse portfolio that includes treatments for neurological disorders, competing with Seelos in the broader pharmaceutical market.
Johnson & Johnson
JNJ
Mkt Cap645.95B
Johnson & Johnson, through its pharmaceutical division Janssen, develops treatments for neurological and mental disorders, competing with Seelos.
Merck
MRK
Mkt Cap366B
Merck & Co., Inc. has a diversified portfolio that includes drug development for neurological diseases, making it a competitor in the same therapeutic area as Seelos.

About

SEELOS THERAPEUTICS INC
Show more...
CEO
Dr. Raj Mehra J.D., Ph.D.
Country
United States
ISIN
US81577F4063
WKN
000A40Q45

Listings

OTC Link
US
SEELQ
MU
DE
NXEN.MU
STU
DE
NXE.STU
MU
DE
NXE.MU

0 Comments

Share your thoughts

FAQ

What is Seelos Therapeutics stock price today?▼
The current price of SEELQ is $0.00 USD — it has increased by +0% in the past 24 hours. Watch Seelos Therapeutics stock price performance more closely on the chart.
What is Seelos Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Seelos Therapeutics stocks are traded under the ticker SEELQ.
Is Seelos Therapeutics stock price growing?▼
SEELQ stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Seelos Therapeutics has showed a +0% increase.
What is Seelos Therapeutics market cap?▼
Today Seelos Therapeutics has the market capitalization of 595.7
What is Seelos Therapeutics revenue for the last year?▼
Seelos Therapeutics revenue for the last year amounts to 2.2M USD.
What is Seelos Therapeutics net income for the last year?▼
SEELQ net income for the last year is -37.88M USD.
In which sector is Seelos Therapeutics located?▼
Seelos Therapeutics operates in the Other sector.
When did Seelos Therapeutics complete a stock split?▼
Seelos Therapeutics has not had any recent stock splits.
Where is Seelos Therapeutics headquartered?▼
Seelos Therapeutics is headquartered in New York, United States.